30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Anthony Quinn

Insider profile

Currently holds positions in Kaleido Biosciences Inc and Spyre Therapeutics Inc

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 51% 68% 82%
Transactions
16 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Kaleido Biosciences Inc None -
President and Chief Executive Officer, Director Spyre Therapeutics Inc Oct. 10, 2019 -
President, Chief Executive Officer, Director Spyre Therapeutics Inc July 1, 2018 - Oct. 10, 2019
Interim Chief Executive Officer, Director Spyre Therapeutics Inc July 18, 2017 - July 1, 2018
Director, Interim Chief Medical Officer Spyre Therapeutics Inc April 1, 2017 - July 1, 2017
Independent Director Spyre Therapeutics Inc March 1, 2016 - April 1, 2017

Anthony Quinn's trades of Generation Bio Co's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-14 2025-01-13 B Purchase
95,245 -43.4%
408.82
US$2,710,862
95,245 -43.4% 408.82 US$2,710,862
2025-01-14 2025-01-10 B Purchase
4,968 +12.6%
178.24
US$2,272,906
4,968 +12.6% 178.24 US$2,272,906
2023-12-05 2023-12-01 B Purchase
56,910 +48.1%
328.52
US$4,147,995
56,910 +48.1% 328.52 US$4,147,995
2022-03-18 2022-03-16 B Purchase
80,079 +17.0%
2.34
US$187,705
80,079 +17.0% 2.34 US$187,705
2022-03-15 2022-03-15 B Purchase
42,417 +9.8%
1.86
US$78,942
42,417 +9.8% 1.86 US$78,942
2022-03-15 2022-03-14 B Purchase
67,472 +18.6%
1.93
US$130,221
67,472 +18.6% 1.93 US$130,221
2022-03-15 2022-03-11 B Purchase
34,777 +10.6%
2.06
US$71,780
34,777 +10.6% 2.06 US$71,780
2021-12-13 2021-12-10 PP Planned purchase
10,526 +3.3%
3.75
US$39,472
10,526 +3.3% 3.75 US$39,472
2021-12-13 2021-12-09 PP Planned purchase
43,108 +15.7%
3.70
US$159,500
43,108 +15.7% 3.70 US$159,500
2020-05-04 2020-04-30 PP Planned purchase
165,000 +44.2%
4.75
US$783,750
165,000 +44.2% 4.75 US$783,750
2019-06-14 2019-06-14 B Purchase
5,282 +1.5%
6.23
US$32,913
5,282 +1.5% 6.23 US$32,913
2019-06-14 2019-06-13 B Purchase
14,406 +4.3%
6.17
US$88,836
14,406 +4.3% 6.17 US$88,836
2019-06-14 2019-06-12 B Purchase
12,217 +3.8%
6.11
US$74,705
12,217 +3.8% 6.11 US$74,705
2019-05-22 2019-05-22 B Purchase
3,809 +1.2%
6.86
US$26,128
3,809 +1.2% 6.86 US$26,128
2019-05-22 2019-05-21 B Purchase
13,794 +4.5%
6.89
US$94,981
13,794 +4.5% 6.89 US$94,981
2019-05-22 2019-05-20 B Purchase
8,989 +3.0%
6.56
US$58,923
8,989 +3.0% 6.56 US$58,923
2019-05-17 2019-05-17 B Purchase
6,218 +2.2%
6.65
US$41,335
6,218 +2.2% 6.65 US$41,335
2019-05-17 2019-05-16 B Purchase
5,520 +1.9%
6.83
US$37,691
5,520 +1.9% 6.83 US$37,691
2019-05-17 2019-05-15 B Purchase
6,256 +2.3%
6.76
US$42,269
6,256 +2.3% 6.76 US$42,269
2019-05-17 2019-02-15 PP Planned purchase
719 +0.3%
7.10
US$5,103
719 +0.3% 7.10 US$5,103